<?xml version="1.0" encoding="UTF-8"?>
<p>Between 1998 and 2016, 4553 ART-naive NCC members underwent genotypic resistance testing. The median sample year was 2009 (interquartile range [IQR], 2006–2013); 90.0% underwent testing after 2003 when pretherapy genotypic resistance testing became routine. Approximately 91% were male and the median age was 39 (IQR, 31–48). The racial/ethnic composition was 46.3% white, 22.4% African American, 20.8% Latino, 8.7% Asian, 0.4% American Indian/Alaska Native, and 1.5% unknown. The HIV-1 acquisition risk factors included men who have sex with men ([MSM] 69.9%), heterosexual contact (20.3%), intravenous drug use (3.8%), transfusion (0.4%), and unrecorded (5.6%).</p>
